<< Part II & III - Therapeutic Groups
Online HML - December 2019
Nervous System |
![]() |
![]() |
Agents for Parkinsonism and Related Disorders Agents for Essential Tremor, Chorea and Related Disorders; Anticholinergics; Dopamine Agonists and Related Agents |
![]() |
Anaesthetics General Anaesthetics; Local Anaesthetics |
![]() |
Analgesics Non-Opioid Analgesics; Opioid Analgesics |
![]() |
Antidepressants Cyclic and Related Agents; Monoamine-Oxidase Inhibitors - Non-Selective; Monoamine-Oxidase Type A Inhibitors; Other Antidepressants; Selective Serotonin Reuptake Inhibitors |
![]() |
Antiepilepsy Drugs Agents for the Control of Status Epilepticus; Control of Epilepsy |
![]() |
Antimigraine Preparations Acute Migraine Treatment; Prophylaxis of Migraine |
![]() |
Antinausea and Vertigo Agents Antinausea and Vertigo Agents |
![]() |
Antipsychotic Agents Depot Injections; General |
![]() |
Anxiolytics Anxiolytics |
![]() |
Multiple Sclerosis Treatments Multiple Sclerosis Treatments; Other Multiple Sclerosis Treatments |
![]() |
Sedatives and Hypnotics Sedatives and Hypnotics |
![]() |
Stimulants / ADHD Treatments Stimulants / ADHD Treatments |
![]() |
Treatments for Dementia Treatments for Dementia |
![]() |
Treatments for Substance Dependence Treatments for Substance Dependence |